123 related articles for article (PubMed ID: 38373107)
41. Androgen receptor expression on circulating tumor cells in metastatic breast cancer.
Fujii T; Reuben JM; Huo L; Espinosa Fernandez JR; Gong Y; Krupa R; Suraneni MV; Graf RP; Lee J; Greene S; Rodriguez A; Dugan L; Louw J; Lim B; Barcenas CH; Marx AN; Tripathy D; Wang Y; Landers M; Dittamore R; Ueno NT
PLoS One; 2017; 12(9):e0185231. PubMed ID: 28957377
[TBL] [Abstract][Full Text] [Related]
42. Quality of cell blocks prepared from residual pleural effusion and bronchial washing samples for immunocytochemistry.
Harabajsa S; Milutin L; Breški A; Ražnjević K; Šimić V; Branica BV; Smojver-Ježek S
Cytopathology; 2023 May; 34(3):264-270. PubMed ID: 36941745
[TBL] [Abstract][Full Text] [Related]
43. Combined use of EpCAM and FRα enables the high-efficiency capture of circulating tumor cells in non-small cell lung cancer.
Chen L; Peng M; Li N; Song Q; Yao Y; Xu B; Liu H; Ruan P
Sci Rep; 2018 Jan; 8(1):1188. PubMed ID: 29352248
[TBL] [Abstract][Full Text] [Related]
44. A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation.
Frithiof H; Welinder C; Larsson AM; Rydén L; Aaltonen K
J Transl Med; 2015 Apr; 13():126. PubMed ID: 25896421
[TBL] [Abstract][Full Text] [Related]
45. Method for semi-automated microscopy of filtration-enriched circulating tumor cells.
Pailler E; Oulhen M; Billiot F; Galland A; Auger N; Faugeroux V; Laplace-Builhé C; Besse B; Loriot Y; Ngo-Camus M; Hemanda M; Lindsay CR; Soria JC; Vielh P; Farace F
BMC Cancer; 2016 Jul; 16():477. PubMed ID: 27417942
[TBL] [Abstract][Full Text] [Related]
46. Circulating tumor cells (CTCs) detected by triple-marker EpCAM, CK19, and hMAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients.
Zhao S; Yang H; Zhang M; Zhang D; Liu Y; Liu Y; Song Y; Zhang X; Li H; Ma W; Zhang Q
Cell Biochem Biophys; 2013 Mar; 65(2):263-73. PubMed ID: 22990361
[TBL] [Abstract][Full Text] [Related]
47. A novel multimarker assay for the phenotypic profiling of circulating tumor cells in hepatocellular carcinoma.
Court CM; Hou S; Winograd P; Segel NH; Li QW; Zhu Y; Sadeghi S; Finn RS; Ganapathy E; Song M; French SW; Naini BV; Sho S; Kaldas FM; Busuttil RW; Tomlinson JS; Tseng HR; Agopian VG
Liver Transpl; 2018 Jul; 24(7):946-960. PubMed ID: 29624843
[TBL] [Abstract][Full Text] [Related]
48. Clonality of circulating tumor cells in breast cancer brain metastasis patients.
Riebensahm C; Joosse SA; Mohme M; Hanssen A; Matschke J; Goy Y; Witzel I; Lamszus K; Kropidlowski J; Petersen C; Kolb-Kokocinski A; Sauer S; Borgmann K; Glatzel M; Müller V; Westphal M; Riethdorf S; Pantel K; Wikman H
Breast Cancer Res; 2019 Sep; 21(1):101. PubMed ID: 31481116
[TBL] [Abstract][Full Text] [Related]
49. Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer.
Giordano A; Gao H; Anfossi S; Cohen E; Mego M; Lee BN; Tin S; De Laurentiis M; Parker CA; Alvarez RH; Valero V; Ueno NT; De Placido S; Mani SA; Esteva FJ; Cristofanilli M; Reuben JM
Mol Cancer Ther; 2012 Nov; 11(11):2526-34. PubMed ID: 22973057
[TBL] [Abstract][Full Text] [Related]
50. Automated Microfluidic Filtration and Immunocytochemistry Detection System for Capture and Enumeration of Circulating Tumor Cells and Other Rare Cell Populations in Blood.
Pugia M; Magbanua MJM; Park JW
Methods Mol Biol; 2017; 1634():119-131. PubMed ID: 28819845
[TBL] [Abstract][Full Text] [Related]
51. Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel.
Blassl C; Kuhlmann JD; Webers A; Wimberger P; Fehm T; Neubauer H
Mol Oncol; 2016 Aug; 10(7):1030-42. PubMed ID: 27157930
[TBL] [Abstract][Full Text] [Related]
52. Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients.
Huebner H; Fasching PA; Gumbrecht W; Jud S; Rauh C; Matzas M; Paulicka P; Friedrich K; Lux MP; Volz B; Gass P; Häberle L; Meier-Stiegen F; Hartkopf A; Neubauer H; Almstedt K; Beckmann MW; Fehm TN; Ruebner M
BMC Cancer; 2018 Feb; 18(1):204. PubMed ID: 29463222
[TBL] [Abstract][Full Text] [Related]
53. Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma.
Poruk KE; Valero V; Saunders T; Blackford AL; Griffin JF; Poling J; Hruban RH; Anders RA; Herman J; Zheng L; Rasheed ZA; Laheru DA; Ahuja N; Weiss MJ; Cameron JL; Goggins M; Iacobuzio-Donahue CA; Wood LD; Wolfgang CL
Ann Surg; 2016 Dec; 264(6):1073-1081. PubMed ID: 26756760
[TBL] [Abstract][Full Text] [Related]
54. Detection of circulating tumor cells in drainage venous blood from colorectal cancer patients using a new filtration and cytology-based automated platform.
Tsutsuyama M; Nakanishi H; Yoshimura M; Oshiro T; Kinoshita T; Komori K; Shimizu Y; Ichinosawa Y; Kinuta S; Wajima K; Sakakibara Y; Yatabe Y; Ito S; Kodera Y
PLoS One; 2019; 14(2):e0212221. PubMed ID: 30811434
[TBL] [Abstract][Full Text] [Related]
55. Leukocyte-Derived Extracellular Vesicles in Blood with and without EpCAM Enrichment.
Nanou A; Zeune LL; Terstappen LWMM
Cells; 2019 Aug; 8(8):. PubMed ID: 31434250
[TBL] [Abstract][Full Text] [Related]
56. Circulating epithelial cells in patients with benign colon diseases.
Pantel K; Denève E; Nocca D; Coffy A; Vendrell JP; Maudelonde T; Riethdorf S; Alix-Panabières C
Clin Chem; 2012 May; 58(5):936-40. PubMed ID: 22205690
[TBL] [Abstract][Full Text] [Related]
57. High-Efficiency Isolation and Rapid Identification of Heterogeneous Circulating Tumor Cells (CTCs) Using Dual-Antibody-Modified Fluorescent-Magnetic Nanoparticles.
Wang Z; Sun N; Liu H; Chen C; Ding P; Yue X; Zou H; Xing C; Pei R
ACS Appl Mater Interfaces; 2019 Oct; 11(43):39586-39593. PubMed ID: 31577122
[TBL] [Abstract][Full Text] [Related]
58. Current and future role of circulating tumor cells in patients with epithelial ovarian cancer.
Van Berckelaer C; Brouwers AJ; Peeters DJ; Tjalma W; Trinh XB; van Dam PA
Eur J Surg Oncol; 2016 Dec; 42(12):1772-1779. PubMed ID: 27265041
[TBL] [Abstract][Full Text] [Related]
59. EpCAM-independent capture of circulating tumor cells with a 'universal CTC-chip'.
Chikaishi Y; Yoneda K; Ohnaga T; Tanaka F
Oncol Rep; 2017 Jan; 37(1):77-82. PubMed ID: 27840987
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of HER2 expression in urothelial carcinoma cells as a biomarker for circulating tumor cells.
Nini A; Hoffmann MJ; Lampignano R; Große Siemer R; van Dalum G; Szarvas T; Cotarelo CL; Schulz WA; Niederacher D; Neubauer H; Stoecklein NH; Niegisch G
Cytometry B Clin Cytom; 2020 Jul; 98(4):355-367. PubMed ID: 32212383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
